A shadow market for unapproved slimming drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, based on recent findings.
Experimental Drug Gaining Popularity Via Social Media
The experimental drug, which remains in clinical trials, is being promoted by online personalities for its alleged fat-burning properties. Viewers are encouraged to contact these profiles directly for source information, while also obtaining promotional offers.
Thriving Commerce on Social Networks
Additionally, a robust market exists on Telegram, where groups with thousands of participants share comparison images, injection guides and claims of rapid British shipping. Vendors promote the substance there before directing customers to WhatsApp for transactions.
Learning About Retatrutide
Retatrutide is an investigational injection developed by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could assist patients lose up to 25% of their total weight. Nicknamed the “triple G”, the drug is being hailed online as the successor to Ozempic.
Healthcare Experts Voice Worries
However, doctors and pharmacists have warned that the distribution of what remains an unapproved drug in the United Kingdom is a cause for concern and could result in users administering substances of unknown origin.
Some professionals stated the popularity for the experimental drug could be linked to the rising price of approved weight loss treatments such as Mounjaro.
Legal Position and Implementation
Selling retatrutide on TikTok or messaging apps is prohibited in the UK, as it is an unlicensed drug that must not be marketed or supplied for personal consumption under the British medical regulations.
Several influencers attempt to sidestep the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but advertising and supply can still violate pharmaceutical, marketing, and consumer laws, potentially leading to fines, prosecution or prison.
Platform Response and Material Removal
Based on the social media company, the platform has removed problematic content and prohibited associated hashtags and query recommendations. The company said it was committed to maintaining the service secure and allocating resources in strengthening compliance measures.
Digital Marketplace Operations
Research also discovered communities with up to 9,000 participants selling the experimental drug using the platform's built-in search feature, which functions like a public directory. Typing “retatrutide” immediately brings up channels with numerous of members, populated with images of slimming results, glowing reviews and detailed guides for mixing or injecting at home.
Within minutes of joining one group, a seller shared WhatsApp details, where the majority of transactions take place. The vendor sent an guidebook and promised delivery within 48 hours. When questioned whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. None asked about weight, health issues or past usage.
Item Details and Costs
Within these communities, posts show black plastic parcels with postal service stickers, stating to include fresh supplies. One communication read: “It took eight of us to load them this morning.”
Buyers can select between powder vials, prepared at home with purified liquid, or ready-to-use pens typically sold at 160 pounds for 20 milligrams. When questioned how long a pen should last, sellers give contradictory responses varying between a several days to “depends on your body”.
Service Moderation and Security Measures
A spokesperson for Telegram said it actively monitored dangerous content on its service including content that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Warnings
“Individuals are injecting materials they cannot confirm. Even if the science behind this drug is sound, these digital versions may not contain what they advertise,” said a pharmacy expert, the director of pharmacy at Chemist4U.
A medical professional of Asda Online Doctor connected the surge in demand to current price rises for approved slimming medications such as Mounjaro. “With costs rising, patients are using social media. But fake treatments are extremely risky. You can’t be certain what’s inside or whether the environment they were made in was sterile,” she said.
Her staff has previously seen patients harmed by self-injection from unconfirmed suppliers. “We understand the disappointment, but buying from Telegram or WhatsApp is taking chances with your well-being,” said Wyllie. “These materials could be impure or incorrectly dosed.”
Producer Position
A spokesperson from the pharmaceutical company stated retatrutide was in third stage research studies and had not been reviewed or authorized by any regulatory agency globally. “Therefore at this time no one can sell [it] for human use,” they explained, adding that any item “falsely representing itself as a Lilly experimental product not yet authorized … may subject users to possibly significant health risks”.
